Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
76
Stocks News & Analysis
stocks
Netflix: A business that’s nearly flawless
stocks
Trump’s US dollar assault is fuelling CBA’s rise
stocks
Insignia Financial: Revised deal still attractive
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,998.10 | 3.30 | -0.04% |
CAC 40 | 7,850.43 | 106.02 | 1.37% |
DAX 40 | 24,240.82 | 198.92 | 0.83% |
Dow JONES (US) | 45,010.29 | 507.85 | 1.14% |
FTSE 100 | 9,061.49 | 37.68 | 0.42% |
HKSE | 25,584.76 | 46.69 | 0.18% |
NASDAQ | 21,020.02 | 127.33 | 0.61% |
Nikkei 225 | 41,988.18 | 816.86 | 1.98% |
NZX 50 Index | 12,829.21 | 35.15 | 0.27% |
S&P 500 | 6,358.91 | 49.29 | 0.78% |
S&P/ASX 200 | 8,731.90 | 5.30 | -0.06% |
SSE Composite Index | 3,589.02 | 6.73 | 0.19% |